home / stock / mbot / mbot quote
Last: | $1.04 |
---|---|
Change Percent: | -4.05% |
Open: | $1.03 |
Close: | $1.04 |
High: | $1.04 |
Low: | $1.01 |
Volume: | 120,167 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.04 | $1.03 | $1.04 | $1.04 | $1.01 | 120,167 | 07-26-2024 |
$0.9899 | $1.04 | $0.9899 | $1.05 | $0.98 | 246,698 | 07-25-2024 |
$1.02 | $1.09 | $1.02 | $1.09 | $1.015 | 251,683 | 07-24-2024 |
$1.07 | $1.07 | $1.07 | $1.0798 | $1.05 | 187,096 | 07-23-2024 |
$1.06 | $1.09 | $1.06 | $1.1495 | $1.05 | 863,332 | 07-22-2024 |
$1.05 | $1.08 | $1.05 | $1.08 | $1.05 | 83,043 | 07-19-2024 |
$1.08 | $1.11 | $1.08 | $1.11 | $1.065 | 172,409 | 07-18-2024 |
$1.07 | $1.09 | $1.07 | $1.1 | $1.05 | 141,650 | 07-17-2024 |
$1.095 | $1.1 | $1.095 | $1.12 | $1.09 | 197,955 | 07-16-2024 |
$1.095 | $1.08 | $1.095 | $1.1 | $1.08 | 154,779 | 07-15-2024 |
$1.08 | $1.07 | $1.08 | $1.0902 | $1.06 | 157,760 | 07-12-2024 |
$1.06 | $1.07 | $1.06 | $1.09 | $1.06 | 181,614 | 07-11-2024 |
$1.07 | $1.07 | $1.07 | $1.085 | $1.06 | 124,853 | 07-10-2024 |
$1.08 | $1.08 | $1.08 | $1.08 | $1.07 | 118,303 | 07-09-2024 |
$1.08 | $1.12 | $1.08 | $1.12 | $1.06 | 267,401 | 07-08-2024 |
$1.065 | $1.03 | $1.065 | $1.07 | $1.03 | 67,432 | 07-05-2024 |
$1.05 | $0.9905 | $1.05 | $1.11 | $0.9905 | 860,914 | 07-04-2024 |
$1.05 | $0.9905 | $1.05 | $1.11 | $0.9905 | 860,914 | 07-03-2024 |
$0.99 | $0.97 | $0.99 | $0.9993 | $0.963 | 182,335 | 07-02-2024 |
$1.01 | $1.02 | $1.01 | $1.02 | $0.98 | 128,481 | 07-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Microbot Medical Inc. Company Name:
MBOT Stock Symbol:
NASDAQ Market:
Microbot Medical Inc. Website:
BRAINTREE, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Endovascular Robotic Surgical System, today announces it has received Institutional Review Board (IRB) approval and signed a clinical trial agreement with Memor...
Baptist Hospital of Miami is the second site to perform clinical procedures as part of the Company’s Pivotal Human Clinical Trial. The clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY ® Endovascular R...
The first clinical case was performed at Brigham and Women’s Hospital The clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY ® Endovascular Robotic Surgical System BRAINTREE, Mass., July 08, 2024 (G...